BIOFRONTERA AG |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.065 EUR | -8.78% |
|
-17.72% | -63.60% |
| May. 15 | Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $7.9M, vs. Street Est of $10.9M | MT |
| Apr. 30 | Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 10.1M | - | - | - | - | - | |
| 739B | ||||||
| 598B | ||||||
| 353B | ||||||
| 318B | ||||||
| 285B |
- Stock Market
- Equities
- B8FK Stock
- Charts Biofrontera AG
- Sector Chart
